Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Generex stock in Canada

Own Generex shares in just a few minutes.

Generex is a business based in the US. Generex stocks (GNBT.US) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $0.053 – the same closing value as a week prior. Generex employs 15 staff and has a trailing 12-month revenue of around $692,762.

How to buy Generex stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – GNBT. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners

CIBC Investor's Edge

  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers

  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Promoted for Free Trades

National Bank Direct Brokerage

  • Commission-free trading
  • Several account types available
  • Access to array of research tools

How has Coronavirus impacted Generex's stock price?

Since the stock market crash in March caused by coronavirus, Generex's stock price has had significant negative movement.

Its last market close was $0.0001, which is 99.98% down on its pre-crash value of $0.62 and 442,900.00% down on the lowest point reached during the March crash when the stocks fell as low as $0.443.

If you had bought $1,000 worth of Generex stocks at the start of February 2020, those stocks would have been worth $1,055.89 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $0.20.

Generex stock price

Use our graph to track the performance of GNBT stocks over time.

Generex stocks at a glance

Information last updated 2022-12-29.
Latest market close$0.0001
52-week range$0.0001 - $0.005
50-day moving average $0.0009
200-day moving average $0.0056
Wall St. target price$6
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.373

Buy Generex stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Available Asset Types Stock Trading Fee Account Fee Table description Signup Offer Offer
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$0 if conditions met, or $100
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Get 100 free online stock or ETo 24F trades and up to $3,000 cash back. Conditions apply.
Get 100 free online stock or ETF trades and up to $3,000 cash back. Conditions apply.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
National Bank Direct Brokerage
Stocks, Bonds, Options, Mutual Funds, GICs
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
Get $0 commission on all transactions with promo code: finder
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Get $50 in free trades when you fund your account with a minimum of $1,000.
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.

Generex price performance over time

Historical closes compared with the last close of $0.0001

3 months (2022-12-23) 0.0001
6 months (2022-09-23) -90.00%
1 year (2022-03-23) -96.67%
2 years (2021-03-23) -99.97%
3 years (2020-03-23) -99.98%
5 years (2018-03-23) -100.00%

Generex financials

Revenue TTM USD$692,762
Gross profit TTM USD$2.1 million
Return on assets TTM -43.84%
Return on equity TTM -1772.71%
Profit margin 0%
Book value $-0.484
Market capitalisation USD$71,068

TTM: trailing 12 months

Generex stock dividends

We're not expecting Generex to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.

Have Generex stocks ever split?

Generex stocks were split on a 7:5 basis on 25 February 2020. So if you had owned 5 shares the day before before the split, the next day you'd have owned 7 shares. This wouldn't directly have changed the overall worth of your Generex stocks – just the quantity. However, indirectly, the new 28.6% lower stock price could have impacted the market appetite for Generex stocks which in turn could have impacted Generex's stock price.

Generex stock price volatility

Over the last 12 months, Generex's stocks have ranged in value from as little as $0.0001 up to $0.005. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a stocks volatility in relation to the market. The market (OTCQB average) beta is 1, while Generex's is -0.0623. This would suggest that Generex's stocks have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Generex has bucked the trend.

Generex overview

Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an oral insulin product. The company is also developing AE37, a synthetic peptide vaccine, which has completed Phase IIb clinical trial to stimulate a potent and specific immune response against tumors expressing the HER-2/neu oncogene in patients with breast cancer and prostate cancer. In addition, it develops, manufactures, and distributes rapid point-of-care in-vitro medical diagnostics for infectious diseases, such as human immunodeficiency virus, tuberculosis, malaria, hepatitis B, hepatitis C, syphilis, and others; and test kits and cassettes for testing infectious diseases, as well as Excellagen, a wound conforming gel. Further, the company is developing immunotherapeutic products and vaccines; and extracellular matrix hydrogel solution, a tissue engineered therapy for the treatment of Ulcerative Colitis. Additionally, it manufactures and sells foot and ankle surgical kits that include plates, screws, and tools; and distributes surgical supplies, orthopedic implants, artificial joints, and biologics, medical devices, and regenerative medicine products. It also serves as the general partner of the Management Services Organization. Generex Biotechnology Corporation was founded in 1983 and is headquartered in Miramar, Florida. On April 23, 2022, an involuntary petition for liquidation under Chapter 7 was filed against Generex Biotechnology Corporation in the U.S. Bankruptcy Court for the Southern District of Florida. On June 6, 2022, the involuntary petition was approved by the Court.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site